Skip to content

CFDs are complex financial instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money. CFDs are complex financial instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

A2 Milk shares: what’s the outlook following China strategy day?

Favourable macro trends – including a growing Chinese middle-class and a more health conscious outlook from consumers both rank as key positives for a2 Milk’s future growth prospects.

A2 Milk (ASX: A2M) share price in focus Source: Bloomberg

As the market mulls the full implications of the Mengniu-backed Bellamy's takeover bid, a number of Australian IMF stocks climbed (then traded flat) in response.

On Monday we saw: BAL-AU skyrocket 55% and Wattle Health Australia Limited rise 12%; BUBS Australia also opened higher.

While a2 Milk Co Ltd (ASX: A2M) also initially soared on this takeover news – rising around 7% on Monday, its share price pulled back sharply during yesterday’s session – closing out the day at A$13.10 per share

This volatility persisted even as a2 Milk unveiled its latest investor Strategy Day presentation – which reiterated the company’s lofty China ambitions.

A2 Milk share price: strategy day in focus

Though nothing fundamentally new was revealed as part of this strategy day – taking place in Shanghai from September 17 to 18 – it has given more ‘colour’ to a2 Milk’s all-important China growth strategy.

The main takeaway: a2 Milk Co Ltd is pursuing the two largest consumer markets in the world – China and the US – which between them have a population of 1,720 million.

Australia’s population by comparison stands at just 25 million.

Broader consumer reach is the name of the game here, with the company interestingly noting that: ‘we have high consumer loyalty, yet relatively low awareness – indicating significant growth opportunity.’

Such comments go far to point out why A2M is aggressively bumping up its marketing spend – anticipating it to hit roughly 12% of revenue in FY20.

To that end, a2 Milk is currently focusing on deepening ‘consumer understanding and engagement’, diversifying the company’s business portfolio, and leveraging technology to innovate rapidly.

This focus, says the company, ‘builds on all that has come before us, but requires stepping up.’

Citi, in a broker note this morning noted that this 'stepping up' is likely to come at a cost: with short-term profitability being sacrificed for near-term top-line growth.

To grow or not to grow?

For investors, growth – and whether or not a company can maintain it – is almost certainly one of the most central questions when stocks trade at high multiples. Even after a2 Milk’s recent downward price action – the company continues to trade at a premium to the broader market: commanding a PE ratio of 36.2, according to the ASX.

Indeed, it was this growth: that came in not-quite-high-enough in FY19 that saw a2 Milk Co Ltd’s shares fall off a cliff during reporting season.

Here, the stock dropped around 14%.

Besides this, and as we previously wrote, a particular concern surrounds FY20 margin guidance – which, according to Morgans – looks to be materially weaker than previously expected.

The corollary here is that it expected that it will be harder (and more expensive for that matter) for a2 Milk to see the kind of revenue growth it did in the past.

Click here to read our full coverage of a2 Milk's FY19 results now.

A changing macro environment

Even as those concerns circle, a growing Chinese middle class, stronger fertility rates and taste changes all have the potential to impact a2 Milk’s growth prospects.

For one, in 2013 the company noted that that the average Chinese woman had her first child at 27. By 2018 that age rose to 30 and by 2028 it’s expected to hit 34.

In addition to this, though a2 Milk has noted that birth rates in China have declined, it may very well be offset by rising fertility rates.

Yet maybe the most important macro trend is the prospect of a wealthier China. Citing research from Euromonitor, a2 Milk notes that the ‘higher income’ and the ‘upper middle’ wealth bands are set to significantly increase in the next decade.

Finally, changing consumer tastes look to be well-backed by these growing wealth bands, as demand for health and wellness products rise in China.

A2 Milk’s share price and its investors have been distinct benefactors of these trends in recent years: as a wealthier middle-class buy up a2 Milk's product at a rapid click.

Tellingly, since April 2015, A2M’s share price has risen over 2,000%.

With these favourable conditions emerging, the question investors will likely now be asking is: can a2 Milk Co Ltd ‘step up’ and take advantage of them?

Only time will tell.


This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.

Act on stock opportunities today

Go long or short on thousands of international stocks with CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Try a risk-free trade
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Friday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.